IP Verse

Modulation Of Afucosylated Species In A Monoclonal Antibody Composition

PatentPatent Analysis

EP3400241

ONCOBIOLOGICS
Application Number
EP17702444A
Filing Date
Jan 5, 2017
Status
Revoked
Apr 29, 2022
Grant Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP3400241B1 was granted to Oncobiologics on Jul 22, 2020 following the initial filing on Jan 5, 2017 under the application number EP17702444A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBApr 21, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents